Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Weidinger

Showing results (71-80 of 274) with videos related to

Pageof 28
Sort By:
The Journal of Allergy and Clinical Immunology|July 4, 2006
Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczemaStephan Weidinger, Natalija Novak, Norman Klopp, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 24, 2025
Improvement and maintenance of clinical outcome assessments in atopic dermatitis with amlitelimabAndrew Blauvelt, Raj Chovatiya, Joseph F Merola, et al.
Allergy|November 11, 2022
Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic reviewConor Broderick, Stefanie Ziehfreund, Karin van Bart, et al.
Dermatology and Therapy|February 4, 2025
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DAREJonathan I Silverberg, Eric L Simpson, Andrew E Pink, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 19, 2026
Psychoeducational schema therapy for psoriasis and atopic dermatitis: a randomized controlled pilot crossover trialRegina von Spreckelsen, Hila Emmert, Jan Hartmann, et al.
The Journal of Allergy and Clinical Immunology|June 9, 2009
Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic diseaseElke Rodríguez, Hansjörg Baurecht, Esther Herberich, et al.
The British Journal of Dermatology|May 31, 2024
Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular dataMatthias Hübenthal, Chengliang Dai, Sara J Brown, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 21, 2024
Facets of pemphigoid: Localized scarring Brunsting-Perry pemphigoidJessica C Lennartz, Ann-Sophie Bohne, Merit Kaeding, et al.
Current Opinion in Allergy and Clinical Immunology|July 31, 2015
Biomarkers for atopic dermatitis: a systematic review and meta-analysisJudith Thijs, Todor Krastev, Stephan Weidinger, et al.
Acta Dermato-Venereologica|August 18, 2025
In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal AntibodyJames G Krueger, Brian S Kim, Stephan Weidinger, et al.
Pageof 28

Showing results (71-80 of 274) with videos related to

Sort By:
Pageof 28
The Journal of Allergy and Clinical Immunology|July 4, 2006
Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczemaStephan Weidinger, Natalija Novak, Norman Klopp, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 24, 2025
Improvement and maintenance of clinical outcome assessments in atopic dermatitis with amlitelimabAndrew Blauvelt, Raj Chovatiya, Joseph F Merola, et al.
Allergy|November 11, 2022
Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic reviewConor Broderick, Stefanie Ziehfreund, Karin van Bart, et al.
Dermatology and Therapy|February 4, 2025
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DAREJonathan I Silverberg, Eric L Simpson, Andrew E Pink, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 19, 2026
Psychoeducational schema therapy for psoriasis and atopic dermatitis: a randomized controlled pilot crossover trialRegina von Spreckelsen, Hila Emmert, Jan Hartmann, et al.
The Journal of Allergy and Clinical Immunology|June 9, 2009
Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic diseaseElke Rodríguez, Hansjörg Baurecht, Esther Herberich, et al.
The British Journal of Dermatology|May 31, 2024
Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular dataMatthias Hübenthal, Chengliang Dai, Sara J Brown, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 21, 2024
Facets of pemphigoid: Localized scarring Brunsting-Perry pemphigoidJessica C Lennartz, Ann-Sophie Bohne, Merit Kaeding, et al.
Current Opinion in Allergy and Clinical Immunology|July 31, 2015
Biomarkers for atopic dermatitis: a systematic review and meta-analysisJudith Thijs, Todor Krastev, Stephan Weidinger, et al.
Acta Dermato-Venereologica|August 18, 2025
In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal AntibodyJames G Krueger, Brian S Kim, Stephan Weidinger, et al.
Pageof 28